# Klockner Of North America – FDA Inspection, Feb 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/klockner-of-north-america/f52801bb-2708-44ac-98b3-e0aa21e2a229
Source feed: FDA_Inspections

> FDA inspection 1081204 of Klockner Of North America, February 27, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081204
- Company Name: Klockner Of North America
- Inspection Date: 2019-02-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1247485 - 2024-08-21
- [FDA Inspection 996793 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/klockner-of-north-america/28f899ab-02be-40f6-8988-d78d36a943e5)
- [FDA Inspection 802887 - 2012-10-03](https://www.keypedia.com/records/fda_inspections/klockner-of-north-america/3aba4384-e2a2-46cf-8dbc-44a76c4aaa14)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lura-d-kelly/f2f257a7-5988-48c1-86e1-a94c5ae97e7d)

Company: https://www.keypedia.com/companies/klockner-of-north-america/feb199c7-0277-4e6d-83c3-dca7bcde5a8a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d